<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37419534</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-1381</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Physical medicine and rehabilitation clinics of North America</Title><ISOAbbreviation>Phys Med Rehabil Clin N Am</ISOAbbreviation></Journal><ArticleTitle>Postacute Sequelae of SARS-CoV-2: Musculoskeletal Conditions and Pain.</ArticleTitle><Pagination><StartPage>585</StartPage><EndPage>605</EndPage><MedlinePgn>585-605</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pmr.2023.04.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1047-9651(23)00031-1</ELocationID><Abstract><AbstractText>Musculoskeletal and pain sequelae of COVID-19 are common in both the acute infection and patients experiencing longer term symptoms associated with recovery, known as postacute sequelae of COVID-19 (PASC). Patients with PASC may experience multiple manifestations of pain and other concurrent symptoms that complicate their experience of pain. In this review, the authors explore what is currently known about PASC-related pain and its pathophysiology as well as strategies for diagnosis and management.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Copley</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozminski</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gentile</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, University of Washington, 1959 Northeast Pacific Street, Box 356390, Seattle, WA 98195-6390, USA; Department of Laboratory Medicine and Pathology, University of Washington, 1959 Northeast Pacific Street Seattle, WA 98195-6390, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geyer</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, University of Washington, 1959 Northeast Pacific Street, Box 356390, Seattle, WA 98195-6390, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedly</LastName><ForeName>Janna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA. Electronic address: Friedlyj@uw.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Phys Med Rehabil Clin N Am</MedlineTA><NlmUniqueID>9102787</NlmUniqueID><ISSNLinking>1047-9651</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009140" MajorTopicYN="Y">Musculoskeletal Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-related pain</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Musculoskeletal conditions</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">Pain</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>8</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>7</Day><Hour>20</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37419534</ArticleId><ArticleId IdType="pmc">PMC10211999</ArticleId><ArticleId IdType="doi">10.1016/j.pmr.2023.04.008</ArticleId><ArticleId IdType="pii">S1047-9651(23)00031-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Centers for Disease Control and Prevention. COVID Data Tracker. Available at: https://covid.cdc.gov/covid-data-tracker. Accessed May, 03 2022.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. COVID Data Tracker Weekly Review. Available at: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html. Accessed August 30, 2022.</Citation></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw Open. 2021;4(10):e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Samrah S.M., Al-Mistarehi A.H., Kewan T., et al. Viral Clearance Course of COVID-19 Outbreaks. J&#xa0;Multidiscip Healthc. 2021;14:555&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7941054</ArticleId><ArticleId IdType="pubmed">33707949</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P., Patel K., Pinto C., et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J&#xa0;Med Virol. 2022;94(1):253&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9(2):129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Coronavirus disease (COVID-19): Post COVID-19 condition. Available at: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition. Accessed August 22, 2022.</Citation></Reference><Reference><Citation>Center for Disease Control and Prevention. Long COVID or Post-COVID Conditions. Available at: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html#print. Accessed August 22, 2022.</Citation></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7&#xa0;months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Romieu A.C., Carton T.W., Saydah S., et al. Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2. JAMA Netw Open. 2022;5(2):e2147053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8817203</ArticleId><ArticleId IdType="pubmed">35119459</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9) doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Foer D., MacPhaul E., et al. PASCLex: A comprehensive post-acute sequelae of COVID-19 (PASC) symptom lexicon derived from electronic health record clinical notes. J&#xa0;Biomed Inform. 2022;125:103951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8590503</ArticleId><ArticleId IdType="pubmed">34785382</ArticleId></ArticleIdList></Reference><Reference><Citation>Alizadeh R., Aghsaeifard Z. Does COVID19 activates previous chronic pain? A case series. Ann Med Surg (Lond) 2021;61:169&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7774008</ArticleId><ArticleId IdType="pubmed">33398236</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp H.I., Corner E., Colvin L.A. Chronic pain after COVID-19: implications for rehabilitation. Br J Anaesth. 2020;125(4):436&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7261464</ArticleId><ArticleId IdType="pubmed">32560913</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanthanna H., Nelson A.M., Kissoon N., et al. The COVID-19 pandemic and its consequences for chronic pain: a narrative review. Anaesthesia. 2022;77(9):1039&#x2013;1050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9350079</ArticleId><ArticleId IdType="pubmed">35848380</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin E.S., Gold L.S., Singh N., et al. Physical function and fatigue recovery at 6&#xa0;months after hospitalization for COVID-19. PMR. 2022 doi: 10.1002/pmrj.12866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12866</ArticleId><ArticleId IdType="pmc">PMC9353339</ArticleId><ArticleId IdType="pubmed">35726518</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoja O., Silva Passadouro B., Mulvey M., et al. Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID. J&#xa0;Pain Res. 2022;15:1729&#x2013;1748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212788</ArticleId><ArticleId IdType="pubmed">35747600</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury A., Lyoubi A., Peiffer-Smadja N., et al. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Rev Neurol. 2021;177(1&#x2013;2):51&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832485</ArticleId><ArticleId IdType="pubmed">33446327</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Navarro-Santana M., Plaza-Manzano G., et al. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis. Pain. 2022;163(7):1220&#x2013;1231.</Citation><ArticleIdList><ArticleId IdType="pubmed">34561390</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F., Demircio&#x11f;lu G&#xfc;neri F., Karde&#x15f; S. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews. Rheumatol Int. 2021;41(7):1263&#x2013;1271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8114015</ArticleId><ArticleId IdType="pubmed">33978818</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojeda A., Calvo A., Cu&#xf1;at T., et al. Characteristics and influence on quality of life of new-onset pain in critical COVID-19 survivors. Eur J Pain. 2022;26(3):680&#x2013;694.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9015597</ArticleId><ArticleId IdType="pubmed">34866276</ArticleId></ArticleIdList></Reference><Reference><Citation>Harapan B.N., Yoo H.J. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) J&#xa0;Neurol. 2021;268(9):3059&#x2013;3071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7826147</ArticleId><ArticleId IdType="pubmed">33486564</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G., Wong J., Henry B.M. Myalgia may not be associated with severity of coronavirus disease 2019 (COVID-19) World J Emerg Med. 2020;11(3):193&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7183921</ArticleId><ArticleId IdType="pubmed">32351656</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L.Q., Huang T., Wang Y.Q., et al. COVID-19 patients&#x2019; clinical characteristics, discharge rate, and fatality rate of meta-analysis. J&#xa0;Med Virol. 2020;92(6):577&#x2013;583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228329</ArticleId><ArticleId IdType="pubmed">32162702</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.T., Porcher R., Pane I., et al. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. 2022;13(1):1812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F., G&#xfc;neri F.D., Karde&#x15f; S. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6&#xa0;months. Clin Rheumatol. 2022;41(1):289&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8553494</ArticleId><ArticleId IdType="pubmed">34713356</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuzun S., Keles A., Okutan D., et al. Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19. Eur J Phys Rehabil Med. 2021;57(4):653&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pubmed">33393277</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur J Intern Med. 2021;92:55&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Islam M., Conroy K., et al. COVID-19 Symptoms Over Time: Comparing Long-Haulers to ME/CFS. Fatigue. 2021;9(2):59&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8411893</ArticleId><ArticleId IdType="pubmed">34484973</ArticleId></ArticleIdList></Reference><Reference><Citation>Attal N., Martinez V., Bouhassira D. Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic. Pain Rep. 2021;6(1):e884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850724</ArticleId><ArticleId IdType="pubmed">33537521</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi D., Gyanpuri V., Pathak A., et al. Neuropathic Pain Associated with COVID-19: a Systematic Review of Case Reports. Curr Pain Headache Rep. 2022;26(8):595&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214475</ArticleId><ArticleId IdType="pubmed">35731363</ArticleId></ArticleIdList></Reference><Reference><Citation>McFarland A.J., Yousuf M.S., Shiers S., et al. Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain. Pain Rep. 2021;6(1):e885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7803673</ArticleId><ArticleId IdType="pubmed">33458558</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay A. A&#xa0;Paradigm for Post-Covid-19 Fatigue Syndrome Analogous to ME/CFS. Front Neurol. 2021;12:701419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8365156</ArticleId><ArticleId IdType="pubmed">34408721</ArticleId></ArticleIdList></Reference><Reference><Citation>Saud A., Naveen R., Aggarwal R., et al. COVID-19 and Myositis: What We Know So Far. Curr Rheumatol Rep. 2021;23(8):63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8254439</ArticleId><ArticleId IdType="pubmed">34216297</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzo C., Chiapparoli I., Corrado A., et al. Rare forms of inflammatory myopathies - part I, generalized forms. Expert Rev Clin Immunol. 2023;19(2):169&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">36469633</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacchi M.C., Tamiazzo S., Lauritano E.C., et al. Case report of COVID-19 in an elderly patient: could SARS-CoV2 trigger myositis? Eur Rev Med Pharmacol Sci. 2020;24(22):11960&#x2013;11963.</Citation><ArticleIdList><ArticleId IdType="pubmed">33275270</ArticleId></ArticleIdList></Reference><Reference><Citation>Movahedi N., Ziaee V. COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis? Pediatr Rheumatol Online J. 2021;19(1):86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8190732</ArticleId><ArticleId IdType="pubmed">34112199</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian J., Xu H. COVID-19 Disease and Dermatomyositis: A Mini-Review. Front Immunol. 2021;12:747116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8792859</ArticleId><ArticleId IdType="pubmed">35095837</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehan W.A., Yoon B.C., Lang M., et al. Paraspinal Myositis in Patients with COVID-19 Infection. AJNR Am J Neuroradiol. 2020;41(10):1949&#x2013;1952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7661075</ArticleId><ArticleId IdType="pubmed">32763902</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh B., Kaur P., Mechineni A., et al. Rhabdomyolysis in COVID-19: Report of Four Cases. Cureus. 2020;12(9):e10686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7523746</ArticleId><ArticleId IdType="pubmed">33005556</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannah J.R., Ali S.S., Nagra D., et al. Skeletal muscles and Covid-19: a systematic review of rhabdomyolysis and myositis in SARS-CoV-2 infection. Clin Exp Rheumatol. 2022;40(2):329&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">35225218</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuthbertson B.H., Roughton S., Jenkinson D., et al. Quality of life in the five years after intensive care: a cohort study. Crit Care. 2010;14(1):R6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2875518</ArticleId><ArticleId IdType="pubmed">20089197</ArticleId></ArticleIdList></Reference><Reference><Citation>Goettler C.E., Pryor J.P., Reilly P.M. Brachial plexopathy after prone positioning. Crit Care. 2002;6(6):540&#x2013;542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC153436</ArticleId><ArticleId IdType="pubmed">12493078</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik G.R., Wolfe A.R., Soriano R., et al. Injury-prone: peripheral nerve injuries associated with prone positioning for COVID-19-related acute respiratory distress syndrome. Br J Anaesth. 2020;125(6):e478&#x2013;e480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7473147</ArticleId><ArticleId IdType="pubmed">32948295</ArticleId></ArticleIdList></Reference><Reference><Citation>Tankisi H., de Carvalho M., Z&#x2019;Graggen W.J. Critical Illness Neuropathy. J&#xa0;Clin Neurophysiol. 2020;37(3):205&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">32358246</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J., Scorza F.A., Scorza C.A., et al. Peripheral neuropathy in COVID-19 is due to immune-mechanisms, pre-existing risk factors, anti-viral drugs, or bedding in the Intensive Care Unit. Arq Neuropsiquiatr. 2021;79(10):924&#x2013;928.</Citation><ArticleIdList><ArticleId IdType="pubmed">34287509</ArticleId></ArticleIdList></Reference><Reference><Citation>Frithiof R., Rostami E., Kumlien E., et al. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study. Clin Neurophysiol. 2021;132(7):1733&#x2013;1740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8012169</ArticleId><ArticleId IdType="pubmed">33875374</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch S., Spuler S., Deja M., et al. Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge. J&#xa0;Neurol Neurosurg Psychiatry. 2011;82(3):287&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">20802220</ArticleId></ArticleIdList></Reference><Reference><Citation>Latronico N., Bolton C.F. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10(10):931&#x2013;941.</Citation><ArticleIdList><ArticleId IdType="pubmed">21939902</ArticleId></ArticleIdList></Reference><Reference><Citation>Druschky A., Herkert M., Radespiel-Tr&#xf6;ger M., et al. Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study. Intensive Care Med. 2001;27(4):686&#x2013;693.</Citation><ArticleIdList><ArticleId IdType="pubmed">11398694</ArticleId></ArticleIdList></Reference><Reference><Citation>Lad H., Saumur T.M., Herridge M.S., et al. Intensive Care Unit-Acquired Weakness: Not just Another Muscle Atrophying Condition. Int J Mol Sci. 2020;21(21) doi: 10.3390/ijms21217840.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21217840</ArticleId><ArticleId IdType="pmc">PMC7660068</ArticleId><ArticleId IdType="pubmed">33105809</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanhorebeek I., Latronico N., Van den Berghe G. ICU-acquired weakness. Intensive Care Med. 2020;46(4):637&#x2013;653.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7224132</ArticleId><ArticleId IdType="pubmed">32076765</ArticleId></ArticleIdList></Reference><Reference><Citation>Caba&#xf1;es-Mart&#xed;nez L., Villad&#xf3;niga M., Gonz&#xe1;lez-Rodr&#xed;guez L., et al. Neuromuscular involvement in COVID-19 critically ill patients. Clin Neurophysiol. 2020;131(12):2809&#x2013;2816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7558229</ArticleId><ArticleId IdType="pubmed">33137571</ArticleId></ArticleIdList></Reference><Reference><Citation>Bednar&#xed;k J., Vondracek P., Dusek L., et al. Risk factors for critical illness polyneuromyopathy. J&#xa0;Neurol. 2005;252(3):343&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pubmed">15791390</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jonghe B., Sharshar T., Lefaucheur J.P., et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288(22):2859&#x2013;2867.</Citation><ArticleIdList><ArticleId IdType="pubmed">12472328</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarneri B., Bertolini G., Latronico N. Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study. J&#xa0;Neurol Neurosurg Psychiatry. 2008;79(7):838&#x2013;841.</Citation><ArticleIdList><ArticleId IdType="pubmed">18339730</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares M.N., Eggelbusch M., Naddaf E., et al. Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19. J&#xa0;Cachexia Sarcopenia Muscle. 2022;13(1):11&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8818659</ArticleId><ArticleId IdType="pubmed">34997689</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., et al. Immunological dysfunction persists for 8&#xa0;months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Khazaal S., Harb J., Rima M., et al. The pathophysiology of Long COVID throughout the renin-angiotensin system. Molecules. 2022;27(9) doi: 10.3390/molecules27092903.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27092903</ArticleId><ArticleId IdType="pmc">PMC9101946</ArticleId><ArticleId IdType="pubmed">35566253</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M., Del Gaudio A., Vittori A., et al. COVID-pain: acute and late-onset painful clinical manifestations in covid-19 - molecular mechanisms and research perspectives. J&#xa0;Pain Res. 2021;14:2403&#x2013;2412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8364364</ArticleId><ArticleId IdType="pubmed">34408485</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiers S., Ray P.R., Wangzhou A., et al. ACE2 and SCARF expression in human dorsal root ganglion nociceptors: implications for SARS-CoV-2 virus neurological effects. Pain. 2020;161(11):2494&#x2013;2501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7572821</ArticleId><ArticleId IdType="pubmed">32826754</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar L.M., Venter C., Vlok M., et al. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci Rep. 2021;41(8) doi: 10.1042/BSR20210611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications. Biochem J. 2022;479(16):1653&#x2013;1708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9484810</ArticleId><ArticleId IdType="pubmed">36043493</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. J&#xa0;Intern Med. 2019;285(4):352&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">30372565</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K., Vanichkachorn G., Cheshire W.P., et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021;31(3):385&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersten J., Baumhardt M., Hartveg P., et al. Long COVID: Distinction between Organ Damage and Deconditioning. J&#xa0;Clin Med Res. 2021;10(17) doi: 10.3390/jcm10173782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10173782</ArticleId><ArticleId IdType="pmc">PMC8432179</ArticleId><ArticleId IdType="pubmed">34501230</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimmig L.M., Rako Z.A., Ziegler S., et al. Long-term comprehensive cardiopulmonary phenotyping of COVID-19. Respir Res. 2022;23(1):263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9491263</ArticleId><ArticleId IdType="pubmed">36131349</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer E., Petrache I., Goldstein N.M., et al. Decreased Fatty Acid Oxidation and Altered Lactate Production during Exercise in Patients with Post-acute COVID-19 Syndrome. Am J Respir Crit Care Med. 2022;205(1):126&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8865580</ArticleId><ArticleId IdType="pubmed">34665688</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin E.S., Gold L.S., Hough C.L., et al. Patient-reported functional outcomes 30&#xa0;days after hospitalization for COVID-19. Pharm Manag PM R. 2022;14(2):173&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662144</ArticleId><ArticleId IdType="pubmed">34585858</ArticleId></ArticleIdList></Reference><Reference><Citation>An Analysis of the Prolonged COVID-19 Symptoms Survey by Patient-Led Research Team. Available at: https://patientresearchcovid19.com/research/report-1/#Support_by_Medical_Stafff. Accessed March 2, 2022.</Citation></Reference><Reference><Citation>Dundumalla S., Barshikar S., Niehaus W.N., et al. A&#xa0;survey of dedicated PASC clinics: Characteristics, barriers and spirit of collaboration. Pharm Manag PM R. 2022;14(3):348&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">35038230</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemelli Against COVID-19 Post-Acute Care Study Group Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res. 2020;32(8):1613&#x2013;1620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7287410</ArticleId><ArticleId IdType="pubmed">32529595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller J.T., McConnell K., Burow P.B., et al. Impacts of the COVID-19 pandemic on rural America. Proc Natl Acad Sci U&#xa0;S&#xa0;A. 2021;118(1) doi: 10.1073/pnas.2019378118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2019378118</ArticleId><ArticleId IdType="pmc">PMC7817144</ArticleId><ArticleId IdType="pubmed">33328335</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng K.J.G., Sun Y., Monnat S.M. COVID-19 Death Rates Are Higher in Rural Counties With Larger Shares of Blacks and Hispanics. J&#xa0;Rural Health. 2020;36(4):602&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7885172</ArticleId><ArticleId IdType="pubmed">32894612</ArticleId></ArticleIdList></Reference><Reference><Citation>Hale N., Meit M., Pettyjohn S., et al. The implications of long COVID for rural communities. J&#xa0;Rural Health. 2022 doi: 10.1111/jrh.12655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jrh.12655</ArticleId><ArticleId IdType="pmc">PMC9115157</ArticleId><ArticleId IdType="pubmed">35289448</ArticleId></ArticleIdList></Reference><Reference><Citation>Sis&#xf3;-Almirall A., Brito-Zer&#xf3;n P., Conangla Ferr&#xed;n L., et al. Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management. Int J Environ Res Public Health. 2021;18(8) doi: 10.3390/ijerph18084350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18084350</ArticleId><ArticleId IdType="pmc">PMC8073248</ArticleId><ArticleId IdType="pubmed">33923972</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Whiteson J.H., Abramoff B., et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC) Pharm Manag PM R. 2022 doi: 10.1002/pmrj.12894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12894</ArticleId><ArticleId IdType="pmc">PMC9538426</ArticleId><ArticleId IdType="pubmed">36169154</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascolini S., Vannini A., Deleonardi G., et al. COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful? Clin Transl Sci. 2021;14(2):502&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536986</ArticleId><ArticleId IdType="pubmed">32989903</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J., Waterboer T., Hippchen T., et al. Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clin Infect Dis. 2022;74(7):1191&#x2013;1198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C., Zuniga M., Crotty K.A., et al. Autoimmune anti-DNA and anti-phosphatidylserine antibodies predict development of severe COVID-19. Life Sci Alliance. 2021;4(11) doi: 10.26508/lsa.202101180.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202101180</ArticleId><ArticleId IdType="pmc">PMC8441539</ArticleId><ArticleId IdType="pubmed">34504035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lingel H., Meltendorf S., Billing U., et al. Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals. J&#xa0;Autoimmun. 2021;122:102682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8214939</ArticleId><ArticleId IdType="pubmed">34214763</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C., Fan J., Luo Y., et al. Prevalence and Characteristics of Rheumatoid-Associated Autoantibodies in Patients with COVID-19. J&#xa0;Inflamm Res. 2021;14:3123&#x2013;3128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8286246</ArticleId><ArticleId IdType="pubmed">34285538</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordhani M., Ruci D., Ruci V. Anti-phospholipid autoantibodies in COVID-19 patients. Ann Rheum Dis. 2021;80(1) https://ard.bmj.com/content/80/Suppl_1/1381.1 Available at:</Citation></Reference><Reference><Citation>Rojas M., Rodr&#xed;guez Y., Acosta-Ampudia Y., et al. Autoimmunity is a hallmark of post-COVID syndrome. J&#xa0;Transl Med. 2022;20(1):129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Taeschler P., Cervia C., Zurbuchen Y., et al. Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures. Allergy. 2022;77(8):2415&#x2013;2430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111424</ArticleId><ArticleId IdType="pubmed">35364615</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahler M., Andrade L.E., Casiano C.A., et al. Anti-DFS70 antibodies: an update on our current understanding and their clinical usefulness. Expert Rev Clin Immunol. 2019;15(3):241&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">30623687</ArticleId></ArticleIdList></Reference><Reference><Citation>Conrad K., R&#xf6;ber N., Andrade L.E.C., et al. The Clinical Relevance of Anti-DFS70 Autoantibodies. Clin Rev Allergy Immunol. 2017;52(2):202&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">27350273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaczmarski P., Karuga F.F., Szmyd B., et al. The Role of Inflammation, Hypoxia, and Opioid Receptor Expression in Pain Modulation in Patients Suffering from Obstructive Sleep Apnea. Int J Mol Sci. 2022;23(16) doi: 10.3390/ijms23169080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23169080</ArticleId><ArticleId IdType="pmc">PMC9409023</ArticleId><ArticleId IdType="pubmed">36012341</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerqueira &#xc9;., Marinho D.A., Neiva H.P., et al. Inflammatory Effects of High and Moderate Intensity Exercise-A Systematic Review. Front Physiol. 2019;10:1550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6962351</ArticleId><ArticleId IdType="pubmed">31992987</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrea L., Grant W.B., Frias-Toral E., et al. Dietary Recommendations for Post-COVID-19 Syndrome. Nutrients. 2022;14(6) doi: 10.3390/nu14061305.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14061305</ArticleId><ArticleId IdType="pmc">PMC8954128</ArticleId><ArticleId IdType="pubmed">35334962</ArticleId></ArticleIdList></Reference><Reference><Citation>Naureen Z., Dautaj A., Nodari S., et al. Proposal of a food supplement for the management of post-COVID syndrome. Eur Rev Med Pharmacol Sci. 2021;25(1 Suppl):67&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">34890036</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikkelsen M.E., Jackson J.C., Hopkins R.O., et al. Peer Support as a Novel Strategy to Mitigate Post-Intensive Care Syndrome. AACN Adv Crit Care. 2016;27(2):221&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">27153311</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Kelly B., Vidal L., McHugh T., et al. Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study. Brain Behav Immun Health. 2022;24:100485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9250701</ArticleId><ArticleId IdType="pubmed">35814187</ArticleId></ArticleIdList></Reference><Reference><Citation>Grech S., Borg J.N., Cuschieri S. Back pain: An aftermath of Covid-19 pandemic? A Malta perspective. Muscoskel Care. 2022;20(1):145&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242888</ArticleId><ArticleId IdType="pubmed">34092018</ArticleId></ArticleIdList></Reference><Reference><Citation>Annino G., Manzi V., Alashram A.R., et al. COVID-19 as a Potential Cause of Muscle Injuries in Professional Italian Serie A Soccer Players: A Retrospective Observational Study. Int J Environ Res Public Health. 2022;19(17) doi: 10.3390/ijerph191711117.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191711117</ArticleId><ArticleId IdType="pmc">PMC9518420</ArticleId><ArticleId IdType="pubmed">36078838</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestro A., Varillas-Delgado D., Morencos E., et al. Injury Incidence Increases after COVID-19 Infection: A Case Study with a Male Professional Football Team. Int J Environ Res Public Health. 2022;19(16) doi: 10.3390/ijerph191610267.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191610267</ArticleId><ArticleId IdType="pmc">PMC9407930</ArticleId><ArticleId IdType="pubmed">36011901</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>